BMRN · Biomarin Pharmaceutical Inc

$66.70 -0.98 (-1.45%) At close · Aug 21

Market Cap

$12.91B

193.57M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-18	2026-08-17
Investor Event Transcript	2026-08-12	2026-09-30
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
8-K/A	2026-07-13	2026-04-27
8-K	2026-06-04	2026-06-02
10-Q	2026-05-05	2026-03-31
8-K	2026-05-04	—
8-K	2026-04-27	—
8-K	2026-04-23	—
DEF 14A	2026-04-21	2026-06-02
Investor Event Transcript	2026-03-31	—
8-K	2026-03-16	—
10-K	2026-02-26	2025-12-31
8-K	2026-02-23	—
8-K	2026-02-12	—
8-K	2026-01-29	—
8-K	2026-01-26	—
8-K	2026-01-12	—
Investor Event Transcript	2025-12-31	—
8-K	2025-12-22	2025-12-19
8-K	2025-12-19	—
8-K	2025-12-17	2025-12-11
10-Q	2025-10-28	2025-09-30
8-K	2025-10-27	—
8-K	2025-10-07	—
8-K	2025-08-11	2025-08-05
10-Q	2025-08-05	2025-06-30
8-K	2025-08-04	—
8-K	2025-08-01	2025-07-30
8-K	2025-05-22	2025-05-20
8-K	2025-05-16	—
10-Q	2025-05-02	2025-03-31
8-K	2025-05-01	—
DEF 14A	2025-04-08	2025-05-20
8-K	2025-03-03	2025-02-25
8-K	2025-02-24	2025-02-20
10-K	2025-02-24	2024-12-31
8-K	2025-02-19	—
10-Q	2024-10-31	2024-09-30
8-K	2024-10-29	—
8-K	2024-09-24	—
8-K	2024-09-04	2024-08-28
8-K	2024-08-28	2024-08-23
8-K	2024-08-22	2024-08-16
8-K	2024-08-05	—
10-Q	2024-08-05	2024-06-30
8-K	2024-05-24	2024-05-21
8-K	2024-05-14	2024-05-09
10-Q	2024-04-26	2024-03-31

Showing 1–50 of 115 filings

Key facts CIK 1048477 CUSIP 09061G101 13F (30d) 505 filings 470 filers Visit website Investor relations